Recent analyses indicate that colorectal cancer (CRC) is increasing sharply among children and young adults, a demographic traditionally considered low‑risk. Data spanning 1999 to 2020 show a six‑fold surge in cases for ages 10‑14, more than a quadrupling for teens 15‑19, and an almost doubling for young adults 20‑24. The trend has prompted experts to question whether CRC in younger patients represents a distinct clinical entity.
Rising Incidence Among Youth
One longitudinal study documented that CRC incidence remained relatively stable from 1999 until 2012, after which the rate for children aged 10‑14 climbed at an estimated 70.54 % per year between 2012 and 2015. That annual growth compounds to roughly a 400 % increase over the three‑year window. While the disease remains rare—approximately one case per 200,000 people under 20 each year, translating to fewer than 100 pediatric diagnoses annually in the United States—the magnitude of the rise is unprecedented.
Aggressive Disease Presentation
Beyond raw numbers, younger patients tend to present with more advanced disease. Research cited by pediatric surgeon Dr. Erica Arnold notes that the majority of CRC cases in this age group are diagnosed at Stage 3 or Stage 4. Patients in Arnold’s cohort were typically evaluated about 12 weeks after initial symptoms, yet despite treatment, cancer recurred in 37 % of cases and 45 % of the cohort died from the disease. Gastrointestinal oncologist Dr. Christopher Lieu suggested that these outcomes may reflect a biologically different cancer rather than solely delayed diagnosis.
Symptoms reported in the study highlight the clinical picture: back and abdominal pain appeared in 74 % of patients, changes in bowel habits in 45.2 %, weight loss in 43 %, and rectal bleeding in 38 %. Dr. Sandra Kavalukas, a colorectal surgeon at the University of Louisville, emphasized that rectal bleeding is the strongest predictor of CRC in individuals under 50, making patients with this symptom 8.5 times more likely to have cancer.
Potential Drivers and Warning Signs
While the precise cause of the upward trend remains uncertain, researchers point to lifestyle and environmental factors. Diets high in ultra‑processed foods, sedentary behavior, and obesity are suspected of disrupting the gut microbiome, fostering chronic inflammation that can lead to malignant mutations. Additional hypotheses include the impact of repeated antibiotic courses on gastrointestinal flora and the possible role of ingested microplastics damaging the bowel’s mucus lining. Dr. Lieu described these influences as a “combination of food, antibiotic use and environmental exposures.”
Given the rarity of CRC in those under 20, routine colonoscopy is not standard for this age group. Nonetheless, clinicians are advised to maintain a high index of suspicion when younger patients present with rectal bleeding, even in the absence of other risk factors. Early recognition and diagnostic evaluation could improve outcomes in a population where disease often presents at an advanced stage.
Mitchell Landsberg is a Senior Technology Correspondent at News Raise. He covers consumer electronics, artificial intelligence, software developments, and digital privacy trends.
